Prostatitis Clinical Trial
Official title:
A Multicenter, Double-Blind Study to Compare the Safety and Efficacy of Levofloxacin to That of Ciprofloxacin in the Treatment of Chronic Prostatitis
The purpose of this study is to compare the safety and effectiveness of levofloxacin to ciprofloxacin in patients with chronic bacterial prostatitis.
Prostatitis (an inflammation of the prostate) is the most common condition affecting the
urinary system in men under 50 years of age. Symptoms of chronic (long-term) prostatitis may
include urgency to urinate, frequency or difficulty in urinating or abdominal, pelvic, or
rectal pain. A frequent cause of prostatitis is bacterial infection, treatable with
antibiotics. This multicenter, double-blind study evaluates the safety and effectiveness of
levofloxacin as compared to ciprofloxacin in patients with chronic bacterial prostatitis.
Patients receive treatment with either levofloxacin or ciprofloxacin for 28 days and are
evaluated during treatment and 5-12 days after the last dose of study drug (posttherapy
visit), and 1 month after the last dose (poststudy visit). Patients are contacted six months
after the last dose to follow up on the potential recurrence of their prostatitis.
Effectiveness is assessed by measuring the ability of the study drug to eliminate bacteria
causing prostatitis and to reduce the signs and symptoms of chronic prostatitis. Laboratory
tests for presence of bacteria are performed throughout the study and at each visit,
patients are questioned as to the relief of their symptoms. Safety evaluations (incidence of
adverse events, physical examinations, laboratory tests) are performed throughout the study.
The study hypothesis is that levofloxacin is at least as effective as ciprofloxacin in
treating chronic bacterial prostatitis without any significant safety issues being observed.
Levofloxacin 500 milligrams (mg) by mouth once daily or ciprofloxacin 500 mg by mouth twice
daily for 28 days
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02246361 -
Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication
|
Phase 4 | |
| Recruiting |
NCT00775515 -
Laparoscopic Prostatectomy for Chronic Prostatitis
|
Phase 2 | |
| Withdrawn |
NCT03027076 -
Microbiome of Urologic Chronic Pelvic Pain Syndrome
|
N/A | |
| Completed |
NCT00402688 -
An Effectiveness and Safety Study for Levofloxacin in Chronic Prostatitis
|
Phase 3 | |
| Suspended |
NCT00194636 -
Effectiveness of Sympathetic Plexus Block on Male Pelvic Pain (Prostatitis, Prostatodynia)
|
Phase 4 | |
| Recruiting |
NCT03720951 -
Applying Pulsed Radiofrequency to the Pudendal Nerve Bilaterally Vs Its Application to Sacral Nerve Roots S2,3 and 4 Bilaterally in Chronic Prostatitis
|
N/A | |
| Completed |
NCT03879486 -
Infectious Outcomes of Povidone-iodine Rectal Cleansing Plus Formalin Disinfection of Needle During Prostate Biopsy
|
N/A | |
| Completed |
NCT01676857 -
Chemokine Mechanisms in Chronic Pelvic Pain
|
||
| Completed |
NCT00169585 -
Levofloxacin For The Management Of Patients With Abnormal Prostate Specific Antigen (PSA)
|
Phase 3 | |
| Completed |
NCT00277511 -
Levofloxacin, Chronic Bacterial Prostatitis
|
Phase 3 | |
| Completed |
NCT01886547 -
2013 Annual National Digital Rectal Exam (DRE) Day Study
|
N/A | |
| Completed |
NCT00701311 -
An Open-Label Study of CC-10004 for Chronic Prostatitis/Chronic Pelvic Pain Syndrome
|
Phase 2 | |
| Terminated |
NCT00194597 -
Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type III
|
Phase 4 | |
| Completed |
NCT03931538 -
Rapid Molecular Organism Identification and Mixed Flora Antibiotic Resistance Profiling (MixAR) Prospective Study
|
N/A | |
| Terminated |
NCT00529386 -
Botox for Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
|
Phase 1 | |
| Completed |
NCT00675298 -
Linkage Analysis in Interstitial Cystitis
|
N/A | |
| Completed |
NCT00103402 -
Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
|
Phase 3 | |
| Completed |
NCT00260637 -
Efficacy Study of Acupuncture to Relieve Symptoms of Chronic Prostatitis
|
Phase 2/Phase 3 | |
| Recruiting |
NCT01932645 -
Etiology Study of Prostatitis
|
||
| Completed |
NCT01826617 -
Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome
|
N/A |